Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.570

-0.040 (-2.48%)

At close: Apr 24, 2025, 4:00 PM

1.570

0.00 (0.00%)

Pre-market: Apr 25, 2025, 7:06 AM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $341.11 million as of April 25, 2025. Its market cap has decreased by -50.92% in one year.

Market Cap

341.11M

Enterprise Value

139.39M

1-Year Change

-50.92%

Ranking

#3161

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $341.11M, a decrease of -88.16%. That is a compound annual growth rate of -27.84%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	341.11M	-23.62%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	737.47B
UnitedHealth Group	393.35B
Johnson & Johnson	375.67B
AbbVie	310.92B
Novo Nordisk	266.18B
Abbott Laboratories	224.37B
Novartis AG	211.63B
AstraZeneca	210.34B

Market Cap Rankings